INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

71,174 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
60.0K sh
Oct 22, 2026Oct 23, 2026
Page 182 of 1780
← PrevNext →
traded Oct 22, 2026
+1d
SEC Form 4

Evidence

4
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
34.4K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$463K
2,728 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$267K
1,564 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$376K
60.0K sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

3
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

3
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise · 10b5-1 plan
M—
30.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

2
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,738
135 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

1
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$154K
900 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

1
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$93K
552 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

1
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$19K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$13K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$37K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M$115K
21.4K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$2,126
85 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
34.4K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector
SNOWSnowflake Inc.
Gift · 10b5-1 plan
G—
16.7K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M$47K
21.9K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M—
21.4K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
6,573 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
6,573 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$15K
335 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
HJ
Honeycutt JenniferDirector, President and CEO
VLTOVeralto Corp
Option exercise · 10b5-1 plan
M—
7,098 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
50.9K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
50.9K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
FJ
Fox-Geen JeremyChief Financial Officer
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M$152K
15.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
6,573 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M$196K
15.3K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
6,573 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
FJ
Fox-Geen JeremyChief Financial Officer
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

57
SR
Sekido RyojiCo-CEO Asia Pacific
ACNAccenture plc
Open-market sale
SELL$1.16M
4,742 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

55
BP
Boswell PeytonDirector
LIQTLIQTECH INTERNATIONAL INC
Open-market purchase
BUY$50K
50.0K sh
Jun 5, 2026Oct 22, 2026
traded Jun 5, 2026
+139dSEC Form 4

Evidence

50
SR
Sekido RyojiCo-CEO Asia Pacific
ACNAccenture plc
Open-market sale
SELL$270K
1,102 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

47
Darrell IssaRSelf
UCUS Treasury Note 3.375% due 09/15/28 CUSIP 91282CNY3
Purchase
BUY$5.00M – $25.00MOct 8, 2026Oct 22, 2026
traded Oct 8, 2026
+14dHouse PTR

Evidence

43
Darrell IssaRSelf
UCUS Treasury Note 3.375% due 09/15/28 CUSIP 91282CNY3
Sale
SELL$5.00M – $25.00MOct 14, 2026Oct 22, 2026
traded Oct 14, 2026
+8dHouse PTR

Evidence

40
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
5,973 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

40
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.17M
6,487 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$45K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence